Consumer Choice and Corporate Bankruptcy Study 2

Last registered on November 28, 2021

Pre-Trial

Trial Information

General Information

Title
Consumer Choice and Corporate Bankruptcy Study 2
RCT ID
AEARCTR-0008411
Initial registration date
November 12, 2021
Last updated
November 28, 2021, 3:01 PM EST

Locations

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information

Primary Investigator

Affiliation
Harvard Business School

Other Primary Investigator(s)

PI Affiliation
Boston College

Additional Trial Information

Status
In development
Start date
2022-04-30
End date
2022-12-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
We employ an online randomized lab experiment to estimate the impact of a company's bankruptcy status on consumer demand for that company's products and services. We identify each participant's hypothetical willingness to pay for a product or service of a firm. We measure how that willingness to pay changes when we exogenously vary information about the firm's bankruptcy status.
External Link(s)

Registration Citation

Citation
Antill, Samuel and Megan Hunter. 2021. "Consumer Choice and Corporate Bankruptcy Study 2." AEA RCT Registry. November 28. https://doi.org/10.1257/rct.8411-1.2000000000000002
Experimental Details

Interventions

Intervention(s)
Our interventions involve randomly providing participants with differing levels of information about a firm's bankruptcy status. The control group is told nothing. The baseline treatment group is told that the firm is currently in Chapter 11 bankruptcy. Supplemental treatment groups are told that the firm is bankrupt and also told additional information about that firm's bankruptcy.
Intervention Start Date
2022-04-30
Intervention End Date
2022-12-31

Primary Outcomes

Primary Outcomes (end points)
Our key outcome variable is the willingness to pay for a product or service of a firm. Our experimental design exogenously varies information about the firm. Notably, we vary the firm's bankruptcy status.
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
We identify each participant's willingness to pay for a product or service of a firm. We measure how that willingness to pay changes when we exogenously introduce information about the firm, including its bankruptcy status.
Experimental Design Details
Not available
Randomization Method
We implement our experiment using a Qualtrics survey. Qualtrics offers a computerized randomization procedure, which we use.
Randomization Unit
We randomize at the participant level.
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
We expect approximately 1800 participants after applying our filters. We exclude individuals that fail attention checks. Because of these filters, and because of the nature of our online survey vendor, we cannot precisely control the number of participants.
Sample size: planned number of observations
We expect approximately 1800 participants after applying our filters. We exclude individuals that fail attention checks. Because of these filters, and because of the nature of our online survey vendor, we cannot precisely control the number of participants.
Sample size (or number of clusters) by treatment arms
There are 100 individuals in each of 18 cells. The cells vary in the information provided and the industry of the hypothetical firm for which we ask follow up questions.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB

Institutional Review Boards (IRBs)

IRB Name
Boston College Institutional Review Board Office for Research Protections
IRB Approval Date
2021-11-10
IRB Approval Number
21.078.01e-2
IRB Name
Harvard University-Area Committee on the Use of Human Subjects
IRB Approval Date
2021-11-01
IRB Approval Number
MOD20-1634-02
Analysis Plan

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information